Insulin Icodec, a rising star in insulin therapy, is an ultra-long-acting basal insulin. It has been approved in countries and regions including Canada, Japan, Australia, China, and the European Union for the treatment of type 2 diabetes mellitus (T2DM) in adults.Findings from multicenter studies indicate that Insulin Icodec demonstrates excellent performance in glycemic control stability […]